All proceeds of this book will go to Fred Frank and Mary Tanner philanthropies, through the Tanner-Frank Foundation. Please see “The Foundation” tab above, for specifics.
When Fred Frank arrived on Wall Street in 1958, he became a key member of a small, whip-smart cadre of young financiers who began challenging the stodgy, risk-averse scions of old-world investment banking. He also became the first banker to specialize in biotechnology, pharmaceuticals, and health care services. Frank’s perpetual search for the new—pioneering technologies, innovative business models, and the “alpha” that creates real investor wealth and groundbreaking industries—has transformed our world.
A Philosopher on Wall Street is an intriguing account of
· a force of verve and ingenuity on Wall Street who oversaw hundreds of IPOS and mergers and acquisitions totaling tens of billions of dollars
· a history of the Street, the rise of technology in America, and the pharma and biotech industries
· colorful stories from top innovators, scientists, executives, and investors about deals, intrigue, genius, booms and busts
This is the story of a master artist of finance whose erudition and grace helped shape our world, who has always believed that inspired science, entrepreneurship and investing are the key to a better future.
I think Fred Frank was the seminal dealmaker in biotech. He has this amazing way of taking a very complicated problem and finding a very simple, straightforward solution.
—Leroy Hood, MD, PhD
Fred was the orchestrator. He was the conductor.
—Kirk Raab, Founding CEO, Genentech
‘Fred’s deal’ . . . became the model of an ideal merger and acquisition involving biotechnology and pharmaceutical companies.
—Life Sciences Foundation Magazine
PRE-ORDER THE BOOK - AVAILABLE SEPTEMBER 14
